Distribution of CYP2D6 alleles and phenotypes in the Brazilian population

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Friedrich, Deise C ^a   Genro, Júlia P ^a   Sortica, Vinicius A ^a   Suarez Kurtz, Guilherme ^b   De Moraes, Maria Elizabete ^c   Pena, Sergio D J ^d   Dos Santos, Ândrea K Ribeiro ^e   Romano Silva, Marco A ^d   Hutz, Mara H ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FEDERAL UNIVERSITY OF PARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6;

ADULT; ALLELE; ANCESTRY GROUP; ARTICLE; BRAZILIAN; CONTROLLED STUDY; CYP2D6 GENE; GENE DOSAGE; GENE DUPLICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; METABOLISM; NORMAL HUMAN; PHENOTYPE; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; BLACK PERSON; BRAZIL; CAUCASIAN; CLINICAL TRIAL; FEMALE; GENETICS; MALE; MULTICENTER STUDY;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BRAZIL; CYTOCHROME P-450 CYP2D6; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE DUPLICATION; GENE FREQUENCY; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84908164583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110691     Document Type: Article

References (59)

1. Ingelman-Sundberg M, Rodriguez-Antona C (2005) Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Philos Trans R Soc Lond B Biol Sci 360: 1563-1570.
2. Bradford LD (2002) CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics 3: 229-243.
3. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, et al. (2004) Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 9: 442-473.
4. Eichelbaum M, Ingelman-Sundberg M, Evans WE (2006) Pharmacogenomics and individualized drug therapy. Annu Rev Med 57: 119-137.
5. Zhou SF (2009) Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet 48: 689-723.
6. Zhou SF (2009) Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part II. Clin Pharmacokinet 48: 761-804.
7. Kimura S, Umeno M, Skoda RC, Meyer UA, Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 45: 889-904.
8. The Human Cytochrome P450 (CYP) Allele Nomenclature Database. Available: http://www.cypalleles.ki.se/. Accessed 14 April 2014.
9. Bernard S, Neville KA, Nguyen AT, Flockhart DA (2006) Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist 11: 126-135.
10. Teh LK, Bertilsson L (2012) Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance. Drug Metab Pharmacokinet 27: 55-67.
11. Gaedigk A (2013) Complexities of CYP2D6 gene analysis and interpretation. Int Rev Psychiatry 25(5): 534-553.
12. Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, et al. (2007) CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genomics 17: 93-101.
13. Zanger UM, Raimundo S, Eichelbaum M (2004) Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 369: 23-37.
14. Kurose K, Sugiyama E, Saito Y (2012) Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet 27: 9-54.
15. Callegari-Jacques SM, Grattapaglia D, Salzano FM, Salamoni SP, Crossetti SG, et al. (2003) Historical genetics: spatiotemporal analysis of the formation of the Brazilian population. Am J Hum Biol 15: 824-834.
16. Salzano FM, Bortolini MC (2002) The evolution and genetics of Latin American Population. Cambrigde, UK: Cambrigde University Press.
17. Pena SD, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, et al. (2011) The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 6: e17063.
18. Zembrzuski VM, Callegari-Jacques SM, Hutz MH (2006) Application of an African Ancestry Index as a genomic control approach in a Brazilian population. Ann Hum Genet 70: 822-828.
19. Leite FP, Callegari-Jacques SM, Carvalho BA, Kommers T, Matte CH, et al. (2008) Y-STR analysis in Brazilian and South Amerindian populations. Am J Hum Biol 20: 359-363.
20. Leite FP, Santos SE, Rodríguez EM, Callegari-Jacques SM, Demarchi DA, et al. (2009) Linkage disequilibrium patterns and genetic structure of Amerindian and non-Amerindian Brazilian populations revealed by long-range X-STR markers. Am J Phys Anthropol 139: 404-412.
21. ∗3 polymorphism. Pharmacogenomics. 2007 8(10): 1299-306.
22. Estrela RC, Ribeiro FS, Carvalho RS, Gregório SP, Dias-Neto E, et al. (2008) Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture. Pharmacogenomics 9: 267-276.
23. Vargens DD, Almendra L, Struchiner CJ, Suarez-Kurtz G (2008) Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol 64: 253-256.
24. Suarez-Kurtz G, Amorim A, Damasceno A, Hutz MH, de Moraes MO, et al. (2010) VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications. Pharmacogenomics 11: 1257-1267.
25. Suarez-Kurtz G, Pena SD, Hutz MH (2012) Application of the F(ST) statistics to explore pharmacogenomic diversity in the Brazilian population. Pharmacogenomics 13(7): 771-777.
26. Sortica VA, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, et al. (2012) Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. Basic Clin Pharmacol Toxicol 110: 460-468.
27. Suarez-Kurtz G, Vargens DD, Santoro AB, Hutz MH, de Moraes ME, et al. (2014) Global Pharmacogenomics: Distribution of CYP3A5 Polymorphisms and Phenotypes in the Brazilian Population. PLoS One 9: e83472.
28. Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, et al. (2014) Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharmacol Ther 95: 376-382.
29. Silveira VS, Canalle R, Scrideli CA, Queiroz RGP, Bettiol H, et al. (2009) Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 33: 898-901.
30. Silveira VS, Canalle R, Scrideli CA, Queiroz RG, Tone LG (2009) Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes in a Brazilian population. Biomarkers 14(2): 111-117.
31. Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Callegari-Jacques SM, et al. (2008) Naturalistic pharmacogenetic study of treatment resistance to typical neuroleptics in European-Brazilian schizophrenics. Pharmacogenet Genomics 18(7): 599-609.
32. Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Gesteira A, et al. (2009) Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians. Pharmacogenomics 10: 1457-1466.
33. Antunes MV, Linden R, Santos TV, Wallemacq P, Haufroid V, et al. (2012) Endoxifen Levels and Its Association With CYP2D6 Genotype and Phenotype: Evaluation of a Southern Brazilian Population Under Tamoxifen Pharmacotherapy. Ther Drug Monit 34: 422-431.
34. Agúndez JA, Ledesma MC, Ladero JM, Benítez J (1995) Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 57: 265-269.
35. Bernal ML, Sinues B, Johansson I, McLellan RA, Wennerholm A, et al. (1999) Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine. Pharmacogenetics 9: 657-660.
36. Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, et al. (1996) Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther 278: 441-446.
37. Lazalde-Ramos BP, Martínez-Fierro MeL, Galaviz-Hernández C, Garza-Veloz I, Naranjo ME, et al. (2014) CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico. Pharmacogenomics 15: 339-348.
38. Suarez-Kurtz G, Paula DP, Struchiner CJ (2014) Pharmacogenomic implications of population admixture: Brazil as a model case. Pharmacogenomics 15: 209-219.
39. Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5: 6-13.
40. Herbild L, Andersen SE, Werge T, Rasmussen HB, Jürgens G (2013) Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs? Basic Clin Pharmacol Toxicol 113: 266-272.
41. de Leon J, Arranz MJ, Ruaño G (2008) Pharmacogenetic testing in psychiatry: a review of features and clinical realities. Clin Lab Med 28: 599-617.
42. The Pharmacogenomics Knowledge Base (PharmGKB). CYP2D6 allelic frequencies available at http://www.pharmgkb.org/download.action?filename=CYP2D6-allele-frequency-table-R2.xlsx.
43. Ramamoorthy A, Skaar TC (2011) Gene copy number variations: it is important to determine which allele is affected. Pharmacogenomics 12: 299-301.
44. Gaedigk A, Twist GP, Leeder JS (2012) CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR. Pharmacogenomics 13: 91-111.
45. Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM (2003) CYP2D6 Genotyping Strategy Based on Gene Copy Number Determination by TaqMan Real-Time PCR. Hum Mut 22: 476-485.
46. Fang H, Liu X, Ramírez J, Choudhury N, Kubo M (2014) Establishment of CYP2D6 reference samples by multiple validated genotyping platforms. Pharmacogenomics J. Epub ahead of print.
47. Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, et al. (2012) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype. Clin Pharmacol Ther 91(2): 321-326.
48. Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, et al. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. Clin Pharmacol Ther 93(5): 402-408.
49. Instituto Brasileiro de Geografia e Estatística website. Available: http://www.ibge.gov.br. Accessed 03 March 2014.
50. Stephens M, Smith N, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
51. Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
52. Weir B, Cockerham C (1984) Estimating F-statistics for the analysis of population structure. Evolution 38: 1358-1370.
53. Weir B (1996) Genetic data analysis II: methods for discrete population genetic data. Sunderland, MA: Sinauer.
54. Excoffier L, Smouse PE, Quattro JM (1992) Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131: 479-491.
55. Keenan K, McGinnity P, Cross TF, Crozier WW, Prodöhl PA (2013) diveRsity: An R package for the estimation of population genetics parameters and their associated errors. Methods Ecol Evol 4(8): 782-788.
56. R Core Team (2014) R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available: http://www.R-project.org.
57. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc 57: 289-300.
58. Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8: 1.
59. Excoffier L, Laval G, Schneider S (2005) Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 1: 47-50.